Delivery formulations

Lonza leader outlines small-molecule trends for 2021 and beyond

06-May-2021 By Jenni Spinner

The head of small-molecule business for the pharma solutions specialist talks about obstacles, and how companies can work to clear them for future success.

Nanoform, Aprecia partner on 3D-printed nanomedicines

27-Apr-2021 By Jenni Spinner

The two companies plan to collaboratively explore ways to combine 3D printing and nanotechnology, in order to create nanoparticle-enabled dosage forms.

Pfizer pours $25m into Vedanta's Phase II IBD study

19-Jan-2021 By Jenni Spinner

The pharma giant has invested in the clinical trial exploring the viability of Vedanta Biosciences’ VE202 inflammatory bowel disease treatment candidate.

Grifols to launch trial for potential COVID-19 therapy

19-Jan-2021 By Jenni Spinner

The subcutaneously administered immunoglobulin, if successful, would provide rapid immunity against the virus behind the deadly global pandemic.

LA customs agents seize $19m in counterfeit Viagra pills

13-Jan-2021 By Jenni Spinner

Authorities discovered the fake Pfizer erectile-dysfunction tablets in one of three cargo containers full of fraudulent goods, recently arrived from China.

AI-driven drug discovery collaboration to tackle neurological diseases

12-Jan-2021 By Jenni Spinner

Sosei Heptares and PharmEnable will harness artificial intelligence-enabled technology and advanced chemistry to explore neurological disease solutions.

Repurposing existing drugs accelerates discovery: XenoTech

12-Jan-2021 By Jenni Spinner

Exploring alternative uses for drugs tapped for other indications, can save considerable time and money in discovery, according to an expert from the CRO.

Lexaria broadens COVID-19 drug exploration program

11-Jan-2021 By Jenni Spinner

The drug delivery platform company is exploring the viability of remdesivir and other potential treatments for the virus using its DehydraTECH technology.

Clinical informatics company raises $21.5m to fund tech

23-Dec-2020 By Jenni Spinner

Ovation.io will harness the funding to develop software and data products supporting drug discovery and development, creating diagnostics and more.

Sanofi joins Aqemia to develop COVID-19 treatments

21-Dec-2020 By Jenni Spinner

The pharma firm will lend support to Aqemia’s high-tech drug discovery tools in order to work on discovery and development of therapies for the virus.

Biomarkers pave the way to personalized care: Quanterix

21-Dec-2020 By Jenni Spinner

An executive from the digital biomarker tech company explains the myriad benefits of biomarker analysis in advancing precision health solutions.

Looking back, thinking ahead: industry leaders talk trends

16-Dec-2020 By Jenni Spinner

Experts from a variety of research and drug development organizations share their thoughts on highlights from 2020, and predict what 2021 might hold.

Sanofi renews WHO partnership on Neglected Tropical Diseases

15-Dec-2020 By Rachel Arthur

Sanofi has made a new five-year, $25m partnership agreement with the World Health Organization (WHO) to fight Neglected Topical Diseases (NTD); and eliminate sleeping sickness by 2030.

Bristol Myers Squibb, Noxopharm to partner on immunotherapy pilot

23-Nov-2020 By Jenni Spinner

The pharma giant and the clinical-stage drug developer will join on a pilot study investigating a candidate’s potential in overcoming resistance of a cancer drug.

Minakem: CM reaps time-saving, quality-boosting benefits

04-Nov-2020 By Jenni Spinner

Leaders from the CDMO discuss how the surging interest in continuous manufacturing can result in cost savings and numerous other advantages.